Department of Surgery, University of Catania, Italy.
Eur Rev Med Pharmacol Sci. 2014 Dec;18(2 Suppl):47-53.
The widespread use of laparoscopy has changed the outcome of gallbladder cancer as a consequence of increasing referral and incidental discovering of earlier stages cancer. Nevertheless, GBC is still associated with a poor prognosis and lymphnodal involvement is a main prognostic factor, important both for staging and for evaluating surgery quality. No consensus exists about the extension of lymphadenectomy to be performed nor about contraindications to extensive resection. A review of literature was so designed to identify the actual role, extension and limits of lymphadenectomy.
A search on Pubmed and Scopus has been performed using the following keywords: gallbladder cancer, gallbladder neoplasm, surgery, laparoscopy, lymphadenectomy to evaluate the prognostic and the therapeutic role of the lymphadenectomy in gallbladder cancer. The retrieved articles were analyzed aimed to evaluate the impact of lymphectomy and of its extension on overall and disease free survival.
Although no consensus still exists over the extension of ideal lymphadenectomy, some points are already clearly established: a part from T1a neoplasms, that do not require further surgery, and T1b for which a regional lymphectomy (N1) is safe and mandatory, more advanced stages require a more aggressive surgery but the fate of paraortic nodal station is still under evaluation. In fact some Authors still believe that the involvement of these nodes determine a so poor prognosis to make uselessly risky their surgical aggression. Other Authors conversely, show that there is not any difference in survival, among node positive patients, between paraortic node positive and no paraortic node positive patients.
The prognosis of gallbladder cancer remains poor because in most patients the diagnosis is made at an advanced stage. Complete surgical resection provides the only curative treatment option in this disease. In order to improve long-term outcome, several surgeons have advocated aggressive surgical resection, including major hepatectomy, pancreatoduodenectomy and extended lymphadenectomy. Even a para-aortic nodal disease shouldn't discourage from pursuing this objective.
腹腔镜的广泛应用改变了胆囊癌的预后,因为越来越多的早期癌症被发现。然而,胆囊癌的预后仍然很差,淋巴结转移是主要的预后因素,对分期和评估手术质量都很重要。对于要进行的淋巴结清扫的范围以及广泛切除的禁忌症,尚无共识。因此,我们对文献进行了综述,以确定淋巴结清扫的实际作用、范围和局限性。
在 Pubmed 和 Scopus 上使用以下关键词进行了搜索:胆囊癌、胆囊肿瘤、手术、腹腔镜、淋巴结清扫,以评估淋巴结清扫在胆囊癌中的预后和治疗作用。分析检索到的文章,评估淋巴结清扫及其范围对总生存和无病生存的影响。
尽管对于理想的淋巴结清扫范围仍未达成共识,但有几点已经明确:除了 T1a 肿瘤(不需要进一步手术)和 T1b 肿瘤(局部淋巴结清扫(N1)安全且必要)外,更晚期的肿瘤需要更积极的手术,但主动脉旁淋巴结站的命运仍在评估中。事实上,一些作者仍然认为,这些淋巴结的受累决定了预后如此差,以至于手术的侵袭性是无用的。相反,其他作者表明,在淋巴结阳性的患者中,主动脉旁淋巴结阳性和无主动脉旁淋巴结阳性的患者之间的生存没有差异。
胆囊癌的预后仍然很差,因为大多数患者在诊断时已经处于晚期。完全手术切除是这种疾病唯一的治愈治疗选择。为了提高长期预后,一些外科医生提倡积极的手术切除,包括广泛的肝切除术、胰十二指肠切除术和扩大淋巴结清扫术。即使存在主动脉旁淋巴结疾病,也不应阻止我们追求这一目标。